Detail Information of Xenobiotics-driven Alterations in 3D Complexes
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0004 Transporter Info | ||||
Gene Name | ABCG2 | ||||
Transporter Name | Breast cancer resistance protein | ||||
Gene ID | |||||
UniProt ID | |||||
Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
Xenobiotic Name | Elacridar Drug Info | ||||
Xenobiotic Type | Discontinued Drug | ||||
MOA | Inhibition | ||||
PubChem CID | 119373 | ||||
Docking Score | -13.063 kcal/mol | ||||
EFMDA Details | EFMDA Info | ||||
Xenobiotic Details | |||||
Formula | C34H33N3O5 | ||||
Molecular Weight | 563.6 | ||||
Canonical SMILES |
COC1=CC=CC2=C1NC3=C(C2=O)C=CC=C3C(=O)NC4=CC=C(C=C4)CCN5CCC6=CC(=C(C=C6C5)OC)OC
|
||||
InChI |
InChI=1S/C34H33N3O5/c1-40-28-9-5-7-26-32(28)36-31-25(33(26)38)6-4-8-27(31)34(39)35-24-12-10-21(11-13-24)14-16-37-17-15-22-18-29(41-2)30(42-3)19-23(22)20-37/h4-13,18-19H,14-17,20H2,1-3H3,(H,35,39)(H,36,38)
|
||||
InChIKey | OSFCMRGOZNQUSW-UHFFFAOYSA-N | ||||
Pharmaceutical Properties | Xlogp | 5.6 | Rotatable Bond Count | 8 | |
Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 7 | ||
Xenobiotic Name | Osimertinib Drug Info | ||||
Xenobiotic Type | Approved Drug | ||||
MOA | Inhibition | ||||
PubChem CID | 71496458 | ||||
Docking Score | -13.005 kcal/mol | ||||
EFMDA Details | EFMDA Info | ||||
Xenobiotic Details | |||||
Formula | C28H33N7O2 | ||||
Molecular Weight | 499.6 | ||||
Canonical SMILES |
CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC
|
||||
InChI |
InChI=1S/C28H33N7O2/c1-7-27(36)30-22-16-23(26(37-6)17-25(22)34(4)15-14-33(2)3)32-28-29-13-12-21(31-28)20-18-35(5)24-11-9-8-10-19(20)24/h7-13,16-18H,1,14-15H2,2-6H3,(H,30,36)(H,29,31,32)
|
||||
InChIKey | DUYJMQONPNNFPI-UHFFFAOYSA-N | ||||
Pharmaceutical Properties | Xlogp | 3.7 | Rotatable Bond Count | 10 | |
Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 7 | ||
Xenobiotic Name | Lopinavir Drug Info | ||||
Xenobiotic Type | Approved Drug | ||||
MOA | Inhibition | ||||
PubChem CID | 92727 | ||||
Docking Score | -12.758 kcal/mol | ||||
EFMDA Details | EFMDA Info | ||||
Xenobiotic Details | |||||
Formula | C37H48N4O5 | ||||
Molecular Weight | 628.8 | ||||
Canonical SMILES |
CC1=C(C(=CC=C1)C)OCC(=O)N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)N4CCCNC4=O)O
|
||||
InChI |
InChI=1S/C37H48N4O5/c1-25(2)34(41-20-12-19-38-37(41)45)36(44)39-30(21-28-15-7-5-8-16-28)23-32(42)31(22-29-17-9-6-10-18-29)40-33(43)24-46-35-26(3)13-11-14-27(35)4/h5-11,13-18,25,30-32,34,42H,12,19-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t30-,31-,32-,34-/m0/s1
|
||||
InChIKey | KJHKTHWMRKYKJE-SUGCFTRWSA-N | ||||
Pharmaceutical Properties | Xlogp | 5.9 | Rotatable Bond Count | 15 | |
Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 5 | ||
Pagination
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.